Glenmark Pharmaceuticals Ltd has said that the GBR 500 deal signed by the company in May has received the second and final upfront payment of $25 million. With this payment, Glenmark has received the entire upfront payment of $50 million from Sanofi pertaining to the GBR - 500 deal.
GBR 500 deal: Glenmark gets $25 m in final upfront payment
Published on
July 11, 2011 09:17
Tags